A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes

NCT00260156 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: vildagliptin
DRUG: placebo

Sponsor

Novartis Pharmaceuticals